Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice

Robin Shoemaker, Lisa R. Tannock, Wen Su, Ming Gong, Susan Gurley, Sean E. Thatcher, Frederique Yiannikouris, Charles M. Ensor, Lisa A. Cassis

Research output: Contribution to journalArticle

Abstract

Background: Obesity increases the risk for hypertension in both sexes, but the prevalence of hypertension is lower in females than in males until menopause, despite a higher prevalence of obesity in females. We previously demonstrated that angiotensin-converting enzyme 2 (ACE2), which cleaves the vasoconstrictor, angiotensin II (AngII), to generate the vasodilator, angiotensin-(1-7) (Ang-(1-7)), contributes to sex differences in obesity-hypertension. ACE2 expression in adipose tissue was influenced by obesity in a sex-specific manner, with elevated ACE2 expression in obese female mice. Moreover, estrogen stimulated adipose ACE2 expression and reduced obesity-hypertension in females. In this study, we hypothesized that deficiency of adipocyte ACE2 contributes to obesity-hypertension of females. Methods: We generated a mouse model of adipocyte ACE2 deficiency. Male and female mice with adipocyte ACE2 deficiency or littermate controls were fed a low (LF) or a high fat (HF) diet for 16 weeks and blood pressure was quantified by radiotelemetry. HF-fed mice of each sex and genotype were challenged by an acute AngII injection, and blood pressure response was quantified. To translate these findings to humans, we performed a proof-of-principle study in obese transwomen in which systemic angiotensin peptides and blood pressure were quantified prior to and after 12 weeks of gender-affirming 17β-estradiol hormone therapy. Results: Adipocyte ACE2 deficiency had no effect on the development of obesity in either sex. HF feeding increased systolic blood pressures (SBP) of wild-type male and female mice compared to LF-fed controls. Adipocyte ACE2 deficiency augmented obesity-induced elevations in SBP in females, but not in males. Obese female, but not obese male mice with adipocyte ACE2 deficiency, had an augmented SBP response to acute AngII challenge. In humans, plasma 17β-estradiol concentrations increased in obese transwomen administered 17β-estradiol and correlated positively with plasma Ang-(1-7)/AngII balance, and negatively to SBP after 12 weeks of 17β-estradiol administration. Conclusions: Adipocyte ACE2 protects female mice from obesity-hypertension, and reduces the blood pressure response to systemic AngII. In obese transwomen undergoing gender-affirming hormone therapy, 17β-estradiol administration may regulate blood pressure via the Ang-(1-7)/AngII balance.

Original languageEnglish (US)
Article number45
JournalBiology of Sex Differences
Volume10
Issue number1
DOIs
StatePublished - Sep 4 2019

Fingerprint

hypertension
Inbred C57BL Mouse
Adipocytes
Blood Pressure
Obesity
Angiotensin II
Estradiol
Hypertension
menopause
Obese Mice
gender
angiotensin converting enzyme 2
Fats
Hormones
Angiotensins
High Fat Diet
Vasoconstrictor Agents
Menopause
Vasodilator Agents
Sex Characteristics

Keywords

  • Angiotensin-(1-7)
  • Angiotensin-converting enzyme 2
  • Blood pressure
  • Obesity
  • Transgender

ASJC Scopus subject areas

  • Gender Studies
  • Endocrinology

Cite this

Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice. / Shoemaker, Robin; Tannock, Lisa R.; Su, Wen; Gong, Ming; Gurley, Susan; Thatcher, Sean E.; Yiannikouris, Frederique; Ensor, Charles M.; Cassis, Lisa A.

In: Biology of Sex Differences, Vol. 10, No. 1, 45, 04.09.2019.

Research output: Contribution to journalArticle

Shoemaker, R, Tannock, LR, Su, W, Gong, M, Gurley, S, Thatcher, SE, Yiannikouris, F, Ensor, CM & Cassis, LA 2019, 'Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice', Biology of Sex Differences, vol. 10, no. 1, 45. https://doi.org/10.1186/s13293-019-0260-8
Shoemaker, Robin ; Tannock, Lisa R. ; Su, Wen ; Gong, Ming ; Gurley, Susan ; Thatcher, Sean E. ; Yiannikouris, Frederique ; Ensor, Charles M. ; Cassis, Lisa A. / Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice. In: Biology of Sex Differences. 2019 ; Vol. 10, No. 1.
@article{4ba8665224b143c28540a7b62f691828,
title = "Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice",
abstract = "Background: Obesity increases the risk for hypertension in both sexes, but the prevalence of hypertension is lower in females than in males until menopause, despite a higher prevalence of obesity in females. We previously demonstrated that angiotensin-converting enzyme 2 (ACE2), which cleaves the vasoconstrictor, angiotensin II (AngII), to generate the vasodilator, angiotensin-(1-7) (Ang-(1-7)), contributes to sex differences in obesity-hypertension. ACE2 expression in adipose tissue was influenced by obesity in a sex-specific manner, with elevated ACE2 expression in obese female mice. Moreover, estrogen stimulated adipose ACE2 expression and reduced obesity-hypertension in females. In this study, we hypothesized that deficiency of adipocyte ACE2 contributes to obesity-hypertension of females. Methods: We generated a mouse model of adipocyte ACE2 deficiency. Male and female mice with adipocyte ACE2 deficiency or littermate controls were fed a low (LF) or a high fat (HF) diet for 16 weeks and blood pressure was quantified by radiotelemetry. HF-fed mice of each sex and genotype were challenged by an acute AngII injection, and blood pressure response was quantified. To translate these findings to humans, we performed a proof-of-principle study in obese transwomen in which systemic angiotensin peptides and blood pressure were quantified prior to and after 12 weeks of gender-affirming 17β-estradiol hormone therapy. Results: Adipocyte ACE2 deficiency had no effect on the development of obesity in either sex. HF feeding increased systolic blood pressures (SBP) of wild-type male and female mice compared to LF-fed controls. Adipocyte ACE2 deficiency augmented obesity-induced elevations in SBP in females, but not in males. Obese female, but not obese male mice with adipocyte ACE2 deficiency, had an augmented SBP response to acute AngII challenge. In humans, plasma 17β-estradiol concentrations increased in obese transwomen administered 17β-estradiol and correlated positively with plasma Ang-(1-7)/AngII balance, and negatively to SBP after 12 weeks of 17β-estradiol administration. Conclusions: Adipocyte ACE2 protects female mice from obesity-hypertension, and reduces the blood pressure response to systemic AngII. In obese transwomen undergoing gender-affirming hormone therapy, 17β-estradiol administration may regulate blood pressure via the Ang-(1-7)/AngII balance.",
keywords = "Angiotensin-(1-7), Angiotensin-converting enzyme 2, Blood pressure, Obesity, Transgender",
author = "Robin Shoemaker and Tannock, {Lisa R.} and Wen Su and Ming Gong and Susan Gurley and Thatcher, {Sean E.} and Frederique Yiannikouris and Ensor, {Charles M.} and Cassis, {Lisa A.}",
year = "2019",
month = "9",
day = "4",
doi = "10.1186/s13293-019-0260-8",
language = "English (US)",
volume = "10",
journal = "Biology of Sex Differences",
issn = "2042-6410",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice

AU - Shoemaker, Robin

AU - Tannock, Lisa R.

AU - Su, Wen

AU - Gong, Ming

AU - Gurley, Susan

AU - Thatcher, Sean E.

AU - Yiannikouris, Frederique

AU - Ensor, Charles M.

AU - Cassis, Lisa A.

PY - 2019/9/4

Y1 - 2019/9/4

N2 - Background: Obesity increases the risk for hypertension in both sexes, but the prevalence of hypertension is lower in females than in males until menopause, despite a higher prevalence of obesity in females. We previously demonstrated that angiotensin-converting enzyme 2 (ACE2), which cleaves the vasoconstrictor, angiotensin II (AngII), to generate the vasodilator, angiotensin-(1-7) (Ang-(1-7)), contributes to sex differences in obesity-hypertension. ACE2 expression in adipose tissue was influenced by obesity in a sex-specific manner, with elevated ACE2 expression in obese female mice. Moreover, estrogen stimulated adipose ACE2 expression and reduced obesity-hypertension in females. In this study, we hypothesized that deficiency of adipocyte ACE2 contributes to obesity-hypertension of females. Methods: We generated a mouse model of adipocyte ACE2 deficiency. Male and female mice with adipocyte ACE2 deficiency or littermate controls were fed a low (LF) or a high fat (HF) diet for 16 weeks and blood pressure was quantified by radiotelemetry. HF-fed mice of each sex and genotype were challenged by an acute AngII injection, and blood pressure response was quantified. To translate these findings to humans, we performed a proof-of-principle study in obese transwomen in which systemic angiotensin peptides and blood pressure were quantified prior to and after 12 weeks of gender-affirming 17β-estradiol hormone therapy. Results: Adipocyte ACE2 deficiency had no effect on the development of obesity in either sex. HF feeding increased systolic blood pressures (SBP) of wild-type male and female mice compared to LF-fed controls. Adipocyte ACE2 deficiency augmented obesity-induced elevations in SBP in females, but not in males. Obese female, but not obese male mice with adipocyte ACE2 deficiency, had an augmented SBP response to acute AngII challenge. In humans, plasma 17β-estradiol concentrations increased in obese transwomen administered 17β-estradiol and correlated positively with plasma Ang-(1-7)/AngII balance, and negatively to SBP after 12 weeks of 17β-estradiol administration. Conclusions: Adipocyte ACE2 protects female mice from obesity-hypertension, and reduces the blood pressure response to systemic AngII. In obese transwomen undergoing gender-affirming hormone therapy, 17β-estradiol administration may regulate blood pressure via the Ang-(1-7)/AngII balance.

AB - Background: Obesity increases the risk for hypertension in both sexes, but the prevalence of hypertension is lower in females than in males until menopause, despite a higher prevalence of obesity in females. We previously demonstrated that angiotensin-converting enzyme 2 (ACE2), which cleaves the vasoconstrictor, angiotensin II (AngII), to generate the vasodilator, angiotensin-(1-7) (Ang-(1-7)), contributes to sex differences in obesity-hypertension. ACE2 expression in adipose tissue was influenced by obesity in a sex-specific manner, with elevated ACE2 expression in obese female mice. Moreover, estrogen stimulated adipose ACE2 expression and reduced obesity-hypertension in females. In this study, we hypothesized that deficiency of adipocyte ACE2 contributes to obesity-hypertension of females. Methods: We generated a mouse model of adipocyte ACE2 deficiency. Male and female mice with adipocyte ACE2 deficiency or littermate controls were fed a low (LF) or a high fat (HF) diet for 16 weeks and blood pressure was quantified by radiotelemetry. HF-fed mice of each sex and genotype were challenged by an acute AngII injection, and blood pressure response was quantified. To translate these findings to humans, we performed a proof-of-principle study in obese transwomen in which systemic angiotensin peptides and blood pressure were quantified prior to and after 12 weeks of gender-affirming 17β-estradiol hormone therapy. Results: Adipocyte ACE2 deficiency had no effect on the development of obesity in either sex. HF feeding increased systolic blood pressures (SBP) of wild-type male and female mice compared to LF-fed controls. Adipocyte ACE2 deficiency augmented obesity-induced elevations in SBP in females, but not in males. Obese female, but not obese male mice with adipocyte ACE2 deficiency, had an augmented SBP response to acute AngII challenge. In humans, plasma 17β-estradiol concentrations increased in obese transwomen administered 17β-estradiol and correlated positively with plasma Ang-(1-7)/AngII balance, and negatively to SBP after 12 weeks of 17β-estradiol administration. Conclusions: Adipocyte ACE2 protects female mice from obesity-hypertension, and reduces the blood pressure response to systemic AngII. In obese transwomen undergoing gender-affirming hormone therapy, 17β-estradiol administration may regulate blood pressure via the Ang-(1-7)/AngII balance.

KW - Angiotensin-(1-7)

KW - Angiotensin-converting enzyme 2

KW - Blood pressure

KW - Obesity

KW - Transgender

UR - http://www.scopus.com/inward/record.url?scp=85071751385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071751385&partnerID=8YFLogxK

U2 - 10.1186/s13293-019-0260-8

DO - 10.1186/s13293-019-0260-8

M3 - Article

C2 - 31484552

AN - SCOPUS:85071751385

VL - 10

JO - Biology of Sex Differences

JF - Biology of Sex Differences

SN - 2042-6410

IS - 1

M1 - 45

ER -